Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$20.45 - $26.49 $28,507 - $36,927
1,394 Added 8.92%
17,028 $367,000
Q4 2023

Feb 13, 2024

SELL
$19.02 - $30.13 $98,010 - $155,259
-5,153 Reduced 24.79%
15,634 $347,000
Q3 2023

Nov 14, 2023

BUY
$30.46 - $46.04 $178,099 - $269,195
5,847 Added 39.14%
20,787 $633,000
Q2 2023

Aug 09, 2023

BUY
$31.57 - $37.73 $32,801 - $39,201
1,039 Added 7.47%
14,940 $558,000
Q1 2023

May 15, 2023

BUY
$29.72 - $41.45 $126,399 - $176,286
4,253 Added 44.08%
13,901 $444,000
Q4 2022

Feb 14, 2023

BUY
$30.23 - $38.71 $291,659 - $373,474
9,648 New
9,648 $344,000
Q1 2020

May 08, 2020

SELL
$7.43 - $24.88 $249,722 - $836,216
-33,610 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$11.01 - $27.92 $370,046 - $938,391
33,610 New
33,610 $1.32 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Cetera Advisors LLC Portfolio

Follow Cetera Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.